Publications


KESTREL and KITE: 52-Week Results From Two Phase III Pivotal Trials of Brolucizumab for Diabetic Macular Edema;
Brown, DM, Emanuelli, A, Bandello, F, Barranco, JJE, Figueira, J, Souied, E, Wolf, S, Gupta, V, Ngah, NF, Liew, G, Tuli, R, Tadayoni, R, Dhoot, D, Wang, L, Bouillaud, E, Wang, Y, Kovacic, L, Guerard, N & Garweg, JG 2022, , American Journal of Ophthalmology, vol. 238, pp. 157-172. https://doi.org/10.1016/j.ajo.2022.01.004

Central nervous system hemorrhage due to chronic lymphocytic leukemia;
Raviskanthan, S, Hall, MN, Mortensen, PW, Chévez-Barrios, P & Lee, AG 2022, , Canadian Journal of Ophthalmology, vol. 57, no. 2, pp. e56-e59. https://doi.org/10.1016/j.jcjo.2021.06.021

Early Residual Fluid-Free Status and Long-Term BCVA Outcomes: A Treatment Agnostic, Post Hoc Analysis of Pooled HAWK and HARRIER Data;
Jhaveri, C, Wykoff, CC, Khanani, AM, Eandi, CM, Chang, A, B, G, Gedif, KA & Singer, M 2022, , American Journal of Ophthalmology, vol. 236, pp. 12-19. https://doi.org/10.1016/j.ajo.2021.10.017

The 5 min meta-analysis: understanding how to read and interpret a forest plot;
on behalf of the R.E.T.I.N.A. study group 2022, , Eye (Basingstoke), vol. 36, no. 4, pp. 673-675. https://doi.org/10.1038/s41433-021-01867-6

Case Report: Neuromyelitis Optica After Treatment of Uveal Melanoma With Nivolumab and Ipilimumab;
Khimani, K, Patel, SP, Whyte, A & Al-Zubidi, N 2022, , Frontiers in Oncology, vol. 12, 806501. https://doi.org/10.3389/fonc.2022.806501

Neuro-Ophthalmic Presentation of Myelomatous Meningitis;
Thomson, AC, Nakawah, MO, Raviskanthan, S, Mortensen, PW & Lee, AG 2022, , Journal of Neuro-Ophthalmology, vol. 42, no. 1, pp. E417-E419. https://doi.org/10.1097/WNO.0000000000001287

EFFECT OF RETINAL THICKNESS VARIABILITY ON VISUAL OUTCOMES AND FLUID PERSISTENCE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Post Hoc Analysis of the HAWK and HARRIER Studies;
Dugel, PU, Jhaveri, CD, Chakravarthy, U, Wykoff, CC, Singh, RP, Hamilton, R, Weissgerber, G, Mulyukov, Z & Holz, FG 2022, , Retina (Philadelphia, Pa.), vol. 42, no. 3, pp. 511-518. https://doi.org/10.1097/IAE.0000000000003349

Calciphylaxis a Giant Cell Arteritis Mimic: A Case Report and Review of the Literature;
Duong, AA, Bhat, N, Bindiganavile, SH, Chevez-Barrios, P & Lee, AG 2022, , Journal of Neuro-Ophthalmology, vol. 42, no. 1, pp. E362-E366. https://doi.org/10.1097/WNO.0000000000001395

Reversible Nutritional Deficiency-Related Conjunctival Xerosis and Optic Neuropathy Secondary to an Exclusively Potato-Based Diet;
Bailey, MD, Mortensen, PW, Raviskanthan, S & Lee, AG 2022, , Journal of Neuro-Ophthalmology, vol. 42, no. 1, pp. E323-E325. https://doi.org/10.1097/WNO.0000000000001217

NEW BIOMARKER QUANTIFYING THE EFFECT OF ANTI-VEGF THERAPY IN EYES WITH PROLIFERATIVE DIABETIC RETINOPATHY ON ULTRAWIDE FIELD FLUORESCEIN ANGIOGRAPHY: RECOVERY Study;
Fan, W, Nittala, MG, Wykoff, CC, Brown, DM, Uji, A, van Hemert, J, Fleming, A, Robertson, G, Sadda, SR & Ip, M 2022, , Retina, vol. 42, no. 3, pp. 426-433. https://doi.org/10.1097/IAE.0000000000003358